British Big Pharma GSK is welcoming President Donald Trump to the U.K. with a hefty gift: a five-year, $30 billion planned investment in U.S. R&D and manufacturing. | British Big Pharma GSK is ...

As AGC Biologics looks to recalibrate its CDMO business, the Seattle-based manufacturer is planning to part ways with a pair of facilities in Colorado. | AGC has started a “structured process” to seek ...

The marketing-related warning letters uploaded Tuesday number nearly 70, though the majority target online pharmacies and ...

Last week, on the same day the Trump administration laid out its plan to rein in direct-to-consumer drug advertising, the FDA ...

A pre-approval inspection by the FDA of Dr. Reddy’s Bachupally biologics production facility earlier this month resulted in ...